Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT06706934

Search for Phenotype-modifying Genes in Patients With Intellectual Disabilities.

Each form of intellectual disability under study is a rare disease in its own right, and it is therefore difficult to study the variability of its expression. It therefore appears necessary to study large series of patients with intellectual disabilities. The objective is to identify variants in phenotype-modifying genes in patients with intellectual disability.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Sex eligibility

All sexes

Study type

Observational

Primary location

About this study

Thanks to the contribution of NGS analyses (exome and genome analysis), the rate of etiological diagnosis in intellectual disability is currently approaching 42% in some meta-analyses. At Bordeaux University Hospital, since 2017, 700 patients have been sequenced for intellectual disability, with a diagnostic rate of 33%.

In genetics, epistasis refers to the interaction between two or more genes. As part of its previous work, BIONOMEEX has developed an algorithm called GWAS-2D (genome wide association study 2 dimension) which makes it possible to observe, from a large number of samples and for a given phenotype, the relationships existing between two loci on the genome.

The GWAS-2DI project involves the reanalysis of exome sequencing data from patients with intellectual disabilities at Bordeaux University Hospital, using a GWAS-2D algorithm developed by BIONOMEEX to search for phenotype-modifying genes.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients with Intellectual Disability or related but not affected by them
  • Major or minor with autorisation of legal representative
  • Exome sequencing in Bordeaux University Hospital between 2018 and 2024

Exclusion criteria

  • Refusal to participate in research protocols
  • Refusal to participate expressed following receipt of information letter.

Treatment and study plan

Primary outcomes

  1. Variants in phenotype-modifying genes

    Time frame: Inclusion visit

    Identifying variants in phenotype-modifying genes in patients with intellectual disability.

Secondary outcomes

  1. Phenotypic traits

    Time frame: Inclusion visit

    Correlation phenotypic traits with additional diagnostic variants

Study contacts

Contact information is provided by the study sponsor or research team.

Vincent MICHAUD, MD

CONTACT

[email protected]

+33556795952

Sponsors and collaborators

Lead sponsor

University Hospital, Bordeaux

Other

Registry information

Official study title

Search for Phenotype-modifying Genes in Patients With Intellectual Disabilities GWAS-2DI.

Acronym: GWAS-2DI

Important dates

Study start
2025
Primary completion
2027
Study completion
2027
First posted
Nov 27, 2024
Registry last updated
Feb 27, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.